Chris Viehbacher

Biogen

Pharma

With highest quarterly sales since '21, Biogen reverses guidance

Biogen has reversed its 2026 revenue guidance, now expecting a mid-single digit increase versus a previous projection of a mid-single digit decline.

Kevin Dunleavy Jul 29, 2026 11:05am

Biogen

Biogen lays out $5.6B to acquire Apellis

Mar 31, 2026 10:32am

Biogen

Biogen looks to shake up SMA status quo with Spinraza HD nod

Mar 30, 2026 9:58am

Biogen

Biogen ticks up sales outlook again as MS franchise holds strong

Oct 30, 2025 1:37pm

Biogen

As new launches take flight, 'a new Biogen' emerges, CEO says

May 1, 2025 11:55am

Viehbacher

Biogen places chips behind 4 new drugs as MS competition mounts

Feb 12, 2025 11:35am